#110: 10 things you should know about MRI scans for MS with neuroradiologist Prof. Mike Wattjes

Prof. Mike Wattjes ist Neuroradiologe an der Medizin. Hochschule Hannover und erklärt gut verständlich, was Du zur MRT bei MS wissen solltest.
#082: Living with neuromyelitis optica (NMO) in Denmark with Leda Bresnov

Meet NMO patient Leda Bresnov, a strong and inspiring woman who is originally from Brazil and has been living in Denmark since 1991. Leda, a wife and mother of two adult children, is overcoming the challenges of Neuromyelitis optica (NMO) and is trying to raise awareness of the disease. In this interview, Leda shares her […]
#080: B-Cell Depletion – Ocrelizumab (Ocrevus), Ofatumumab (Kesimpta, Bonspri), Rituximab (Mabthera, Rituxan), Ublituximab (Briumvi) for active RRMS and SPMS, and early PPMS

Interferon-beta (Avonex, Betaferon, Extavia, Plegrid,y Rebif) is used as a disease-modifying therapy for mild to moderate RRMS, CIS & SPMS.
#078: Cladribine (Mavenclad, Leustat, Litak) for highly active MS

Cladribine (Mavenclad, Leustat, Litak) is an induction therapy the supresses the immun system and is used for highly active MS.
#076: Alemtuzumab (Lemtrada, Campath) for highly active Multiple Sclerosis

Alemtuzumab (Lemtrada, Campath) is a DMT to treat highly active MS and has long-lasting effects and potential severe side effects.
#074: S1P Modulators – Fingolimod (Gilenya), Ozanimod (Zeposia), Ponesimod (Ponvory), Siponimod (Mayzent) for active RRMS & SPMS

Interferon-beta (Avonex, Betaferon, Extavia, Plegrid,y Rebif) is used as a disease-modifying therapy for mild to moderate RRMS, CIS & SPMS.
#073: “Haciendo Lo Invisible, Visible”. Crys’s Journey of Invisible Battles and Visible Triumphs as Latina with MS in the US

Today I’m talking to Crys about her life with multiple sclerosis as a first generation Latina. Crys was diagnosed at age eleven and experienced her most severe episode at age 13 when she was paralyzed from the neck down. She recovered from this episode thanks to the devoted support of her family, especially her mother. […]
#072: Natalizumab (Tysabri, Tyruko) for active relapsing remitting MS

Interferon-beta (Avonex, Betaferon, Extavia, Plegrid,y Rebif) is used as a disease-modifying therapy for mild to moderate RRMS, CIS & SPMS.
#070: Teriflunomide (Aubagio) for relapsing remitting MS

Interferon-beta (Avonex, Betaferon, Extavia, Plegrid,y Rebif) is used as a disease-modifying therapy for mild to moderate RRMS, CIS & SPMS.
#068: Interferon-beta (Avonex, Betaferon, Extavia, Plegridy, Rebif, …) for CIS, RRMS & SPMS

Interferon-beta (Avonex, Betaferon, Extavia, Plegrid,y Rebif) is used as a disease-modifying therapy for mild to moderate RRMS, CIS & SPMS.